Dr. Markus Gershater explains how High Dimensional Experimentation (HDE) revolutionizes assay development by replacing one-factor-at-a-time (OFAT) methods with automated, multivariate workflows.
72% of participants agreed there was a reproducibility crisis in biomedicine, with 27% of participants indicating the crisis was “significant.” The leading perceived cause of irreproducibility was a ...
Some research teams work on replicating prior studies to assess the value of a body of work. AzmanL/E+ via Getty Images Back in high school chemistry, I remember waiting with my bench partner for ...
I read with interest your article on the White House’s response to the replication crisis in biomedical science. You cite the Center for Open Science’s project, which couldn’t replicate 54% of ...
A meadow grasshopper (Pseudochorthippus parallelus). This species is widespread across most of Europe and is commonly used as a model organism in evolutionary biology. If an experiment is repeated ...
As the result of a mandate from Congress, the National Academies will explore the issues of reproducibility and replication in scientific and engineering research. The committee will explore what is ...
The trouble with FDA's move to require only one study for new drugs ...
The workshop addresses the alarming issue of poor reproducibility of published experimental results in the biomedical field. Attendees will learn how to apply effective strategies to perform their ...
Despite decades of discussion around reproducibility, many of the same problems, such as selective reporting, publication bias, and overworked peer reviewers, persist. The question is no longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results